A jury in Delaware unanimously dismissed all allegations of misappropriation against Inhibrx, a Sanofi-owned biotech firm | ...

18 February 2024 While President Biden’s desire to reduce costs at the pharmacy counter is commendable, it is too blunt an ...

A US biopharma firm must pay the damages to Sandoz over a long-running dispute over lung therapy | New Jersey district judge ...

The government’s autumn budget sends a positive signal but a more comprehensive approach is required to unlock the UK’s ...

11 October 2022 European Commission says pharma firm blocked generics over blockbuster MS drug| Teva “engaged in abusive conduct” to “artificially prolong the exclusivity” of Copaxone | Teva could be ...

New hire specialises in guiding life sciences and health tech clients through compliance issues | Work includes US regulations, including those enforced by the FDA, Drug Enforcement Administration and ...